Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone‐sensitive prostate cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone‐sensitive prostate cancer.

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Sathianathen, Niranjan J, Dahm, Philipp, Brown, Sarah Jane, Oestreich, Makinna, Gupta, Shilpa, Konety, Badrinath R, Kunath, Frank
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2019
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353243/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013245
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky